Q3 2023 AddLife AB Earnings Call Transcript
()-&
Good morning everyone, and welcome to the Add Life third quarter presentation. Today we will go through some of the business highlights as well as the financials. And then we will open up for questions and discussions.
We're very happy to report a strong growth in the quarter. All the companies are performing very, very well. And in the Labtech business area, we have a 9% organic currency adjusted growth; and in the Medtech business area, 10% organic growth.
We see the healthy demand in all the segments in which we are active. The increased activity in elective surgery remains strong, and we expect that trend to continue in the coming quarters. Positive market trends are supporting our business in home care, in diagnostics and in research. The EBITDA improved, making adjustments for contingent considerations. And that is true in spite of the fact that we have some negative impact from the profitability in AddVision.
The cash flow is significantly improving. We are releasing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |